Cutting Edge: The Heat Shock Protein gp96 Activates Inflammasome-Signaling Platforms in APCs
- 15 October 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 201 (8) , 2209-2214
Abstract
Several heat shock proteins (HSPs) prime immune responses, which are, in part, a result of activation of APCs. APCs respond to these immunogenic HSPs by upregulating costimulatory molecules and secreting cytokines, including IL-1β. These HSP-mediated responses are central mediators in pathological conditions ranging from cancer, sterile inflammation associated with trauma, and rheumatoid arthritis. We tested in this study the requirement of inflammasomes in the release of IL-1β by one immunogenic HSP, gp96. Our results show that murine APCs activate NLRP3 inflammasomes in response to gp96 by K+ efflux. This is shown to initiate inflammatory conditions in vivo in the absence of additional known inflammasome activators or infection. These results document a novel mechanism by which proteins of endogenous origin, the HSPs, can modulate an inflammatory response following their release from aberrant cells.Keywords
This publication has 23 references indexed in Scilit:
- Establishment of Tumor-Associated Immunity Requires Interaction of Heat Shock Proteins with CD91Cancer Immunology Research, 2014
- Identification of the Cellular Sentinels for Native Immunogenic Heat Shock Proteins In VivoThe Journal of Immunology, 2013
- CD91-dependent programming of T-helper cell responses following heat shock protein immunizationNature Communications, 2011
- The Inflammasome NLRs in Immunity, Inflammation, and Associated DiseasesAnnual Review of Immunology, 2011
- AIM2 activates the inflammasome and cell death in response to cytoplasmic DNANature, 2009
- Heat-shock protein-based vaccines for cancer and infectious diseaseExpert Review of Vaccines, 2008
- Cryopyrin activates the inflammasome in response to toxins and ATPNature, 2006
- Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathwayInternational Immunology, 2000
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1FEBS Letters, 1995
- Tumor rejection antigens of chemically induced sarcomas of inbred mice.Proceedings of the National Academy of Sciences, 1986